Several targeting molecules have been successfully used to direct therapeutic drugs or drug carriers before performing PCI, such as a chimeric construct with vascular endothelial growth factor and gelonin for vascular targeting33, or antibodies against Her2 receptor24, epidermal growth factor receptor34 or EpCAM35 to target cancer cells. This evidence concerns the gene VEGFA and cancer.